QSAR Modeling Using Large-Scale Databases: Case Study for HIV-1 Reverse Transcriptase Inhibitors-Reference-Cited by-同舟云学术

QSAR Modeling Using Large-Scale Databases: Case Study for HIV-1 Reverse Transcriptase Inhibitors

Published:2015-06-29 Issue:7 Volume:55 Page:1388-1399
ISSN:1549-9596
Container-title:Journal of Chemical Information and Modeling
language:en
Short-container-title:J. Chem. Inf. Model.

Author:

Tarasova Olga A.¹,Urusova Aleksandra F.¹,Filimonov Dmitry A.¹,Nicklaus Marc C.²,Zakharov Alexey V.²,Poroikov Vladimir V.¹

Affiliation:

1. Institute of Biochemical Chemistry, 10-8, Pogodinskaya St., 119121, Moscow, Russia

2. CADD Group, Chemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, DHHS, NCI-Frederick, 376 Boyles St., Frederick, Maryland 21702, United States

Funder

National Institutes of Health

Russian Foundation for Basic Research

Publisher

American Chemical Society (ACS)

Subject

Library and Information Sciences,Computer Science Applications,General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jcim.5b00019

Reference31 articles.

1. Comparability of Mixed IC50 Data – A Statistical Analysis

2. Making every SAR point count: the development of Chemistry Connect for the large-scale integration of structure and bioactivity data

3. Towards a gold standard: regarding quality in public domain chemistry databases and approaches to improving the situation

4. The Experimental Uncertainty of Heterogeneous Public Ki Data

5. Selectivity Data: Assessment, Predictions, Concordance, and Implications

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ligand-based virtual screening and biological evaluation of inhibitors of Mycobacterium tuberculosis H37Rv;SAR and QSAR in Environmental Research;2024-01-02

2. Quantitative Structure–Activity Relationship in the Series of 5-Ethyluridine, N2-Guanine, and 6-Oxopurine Derivatives with Pronounced Anti-Herpetic Activity;Molecules;2023-11-22

3. In Silico Estimation of the Safety of Pharmacologically Active Substances Using Machine Learning Methods: A Review;Safety and Risk of Pharmacotherapy;2023-11-13

4. Exploring natural products as multi-target-directed drugs for Parkinson’s disease: an in-silico approach integrating QSAR, pharmacophore modeling, and molecular dynamics simulations;Journal of Biomolecular Structure and Dynamics;2023-09-27

5. Identifying Differences in the Performance of Machine Learning Models for Off-Targets Trained on Publicly Available and Proprietary Data Sets;Chemical Research in Toxicology;2023-07-13